Related Subjects:
|Systemic Lupus Erythematosus (SLE)
|Drug induced Lupus Erythematosus
|Discoid lupus erythematosus (DLE)
|Neonatal Lupus Erythematosus
|Raynaud's Phenomenon
|Polymyositis
|Dermatomyositis
|Polyarteritis nodosa
|Rheumatoid Arthritis
|Systemic Sclerosis (Scleroderma)
|Rheumatology Autoantibodies
|Overlap Syndrome
|Inclusion Body Myositis
|Inflammatory Myopathies
|Psoriatic Arthritis
|Adult Onset Still's Disease
|Alkaptonuria
|Behcet's Syndrome
๐ Drug-induced lupus erythematosus (DILE) is an autoimmune condition caused by a reaction to certain medications.
โ ๏ธ It tends to be more benign than idiopathic SLE, with rare renal, skin, or neurological involvement.
๐งฌ About
- Resembles systemic lupus erythematosus but usually milder.
- Key distinction: renal, neurological, and cutaneous involvement is uncommon.
- Improves after withdrawal of the offending drug.
โ๏ธ Risk Factors
- Older age group compared with classic lupus.
- Pharmacogenetics: slow acetylator status.
- Genetic predisposition: HLA DR4, DR2, DR3, DR0301, DQB1, B8, C4 null allele.
๐ Common Culprit Drugs
- High yield: Isoniazid, Procainamide, Hydralazine, Penicillamine, Phenytoin.
- Biologics: TNF-ฮฑ inhibitors (etanercept, infliximab, adalimumab).
- Other causes: Minocycline, Quinidine, Methyldopa, Chlorpromazine, Sulfasalazine, Capoten (captopril).
- Levamisole-adulterated cocaine โ increasingly recognised cause.
๐ฉบ Clinical Features
- Onset: usually after 3โ6 months of therapy (sometimes up to 10 years).
- Systemic: fever, malaise, weight loss.
- MSK: polyarthritis or migratory arthralgia (often symmetrical).
- Serositis: pleuritis or pericarditis.
- Skin: annular or papulosquamous lesions on sun-exposed areas (less severe than idiopathic SLE).
๐ฌ Investigations
- FBC & U&E: usually normal.
- Complement (C3/C4): usually normal (contrast with SLE where low).
- ANA: positive in ~90% (homogeneous pattern).
- Anti-dsDNA: typically negative.
- Anti-histone antibodies: positive in >95% of DILE cases โ hallmark test.
- ESR: may be raised.
๐ ๏ธ Management
- ๐ซ Stop the causative drug โ symptoms usually resolve within weeks to months.
- NSAIDs or low-dose steroids for symptomatic relief in persistent arthritis/serositis.
๐ Exam Tip โ DILE vs SLE
| Feature | Drug-Induced Lupus | Systemic Lupus (SLE) |
| Age | Older | Younger (esp. women of childbearing age) |
| Time course | Monthsโyears after exposure | Chronic/relapsing |
| Renal/CNS involvement | Rare | Common |
| ANA | Positive, homogeneous | Positive, mixed patterns |
| Anti-dsDNA | Negative | Positive (specific) |
| Anti-histone | Positive in >95% | Positive in 50โ70% |
| Management | Stop drug โ resolution | Immunosuppression needed |
๐ References
Cases โ Drug-Induced Lupus Erythematosus (DILE)
- Case 1 โ Hydralazine-related ๐: A 54-year-old man on long-term hydralazine for resistant hypertension develops fatigue, arthralgia, low-grade fever, and a photosensitive rash. Bloods: ANA positive, anti-histone antibody positive, normal complement levels. Diagnosis: drug-induced lupus from hydralazine. Symptoms improve on drug withdrawal.
- Case 2 โ Procainamide-associated โค๏ธ: A 61-year-old woman treated with procainamide for atrial fibrillation presents with pleuritic chest pain and arthralgia. Exam: small pleural effusion. Autoantibodies: anti-histone strongly positive, dsDNA negative. Diagnosis: drug-induced lupus from procainamide. Managed with discontinuation and NSAIDs.
- Case 3 โ Anti-TNF induced ๐: A 45-year-old man with rheumatoid arthritis on infliximab reports photosensitive rash, oral ulcers, and joint pains. ANA and anti-dsDNA are positive, but disease resolves after stopping the drug. Diagnosis: anti-TNFโinduced lupus-like syndrome. Managed with drug cessation and short steroid course.
Teaching Point ๐ฉบ: DILE resembles SLE but usually spares the kidneys and CNS. Hallmarks are exposure to culprit drugs (hydralazine, procainamide, isoniazid, minocycline, anti-TNF agents), positive ANA/anti-histone antibodies, and resolution after withdrawal.